Skip to main content

Table 3 Treatment outcomes by age group

From: Effectiveness and safety of artemether–lumefantrine versus artesunate–amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial

Treatment Treatment outcome ≤5 years, n = 496 (%) >5 years, n = 164 (%) P-value
AL PCR unadjusted
ACPR 109 (43.3) 50 (61.7) 0.004
TTF 143 (56.7) 31 (38.3)  
PCR adjusted
ACPR 192 (76.2) 67 (82.7) 0.276
TTF 60 (23.8) 14 (17.3)  
ASAQ PCR unadjusted
ACPR 154 (63.1) 65 (78.3) 0.013
TTF 90 (36.9) 18 (21.7)  
PCR adjusted
ACPR 199 (81.6) 76 (91.6) 0.053
TTF 45 (18.4) 7 (8.4)